U.S., April 25 -- ClinicalTrials.gov registry received information related to the study (NCT06942377) titled 'Calcium Channel Blocker Amlodipine for Endometrial Cancer Therapy' on March 10.
Brief Summary: To explore the treatment efficacy of Progesterone Therapeutic Regimen Plus Azelnidipine in patients with atypical endometrial hyperplasia (AEH) and early endometrial carcinoma (EEC) for conservative treatment.
Study Start Date: April 16
Study Type: INTERVENTIONAL
Condition:
Endometrial Cancer
Atypical Endometrial Hyperplasia
Intervention:
DRUG: Amlodipine
Progesterone regimen (oral medroxyprogesterone acetate tablet 250mg-500mg/ day or Mirena +GnRHa3.75mg subcutaneous injection monthly) combined with Amlodipine
Recruitment Status:...